Yvonne Greenstreet

Chief Executive Officer at Alnylam Pharmaceuticals Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: Alnylam Pharmaceuticals Inc., 3 years.

Alnylam Pharmaceuticals Inc. Director · Chief Executive Officer
3 years · Since 2023

Chief executive roles

Alnylam Pharmaceuticals Inc. · Chief Executive Officer
Dates unknown

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 19, 2026 Alnylam Pharmaceuticals Inc. Grant or award +107 — —
Mar 4, 2026 Alnylam Pharmaceuticals Inc. Open-market sale −135 $319.03 $43,069
Mar 4, 2026 Alnylam Pharmaceuticals Inc. Open-market sale −129 $320.01 $41,281
Mar 4, 2026 Alnylam Pharmaceuticals Inc. Open-market sale −274 $320.81 $87,902
Mar 4, 2026 Alnylam Pharmaceuticals Inc. Open-market sale −368 $321.82 $118,430
Mar 4, 2026 Alnylam Pharmaceuticals Inc. Open-market sale −444 $323.01 $143,416
Mar 4, 2026 Alnylam Pharmaceuticals Inc. Open-market sale −973 $323.84 $315,096
Mar 4, 2026 Alnylam Pharmaceuticals Inc. Open-market sale −345 $324.88 $112,084
Mar 4, 2026 Alnylam Pharmaceuticals Inc. Open-market sale −265 $325.67 $86,303
Mar 2, 2026 Alnylam Pharmaceuticals Inc. Grant or award +13,844 — —
Mar 2, 2026 Alnylam Pharmaceuticals Inc. Open-market sale −200 $323.62 $64,724
Mar 2, 2026 Alnylam Pharmaceuticals Inc. Open-market sale −382 $324.65 $124,016
Mar 2, 2026 Alnylam Pharmaceuticals Inc. Open-market sale −1,098 $325.63 $357,542
Mar 2, 2026 Alnylam Pharmaceuticals Inc. Open-market sale −1,669 $326.81 $545,446
Mar 2, 2026 Alnylam Pharmaceuticals Inc. Open-market sale −1,399 $327.67 $458,410

Questions about Yvonne Greenstreet

What boards is Yvonne Greenstreet on?

Yvonne Greenstreet sits on the board of Alnylam Pharmaceuticals Inc.

What company is Yvonne Greenstreet the CEO of?

Yvonne Greenstreet is Chief Executive Officer of Alnylam Pharmaceuticals Inc.

How long has Yvonne Greenstreet served on boards?

Our records show at least 4 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.